Respiratory Syncytial Virus is a growing health concern for Indian infants. Efforts for maternal RSV vaccine faces challenges ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA (clesrovimab-cfor) , a ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

Add articles to your saved list and come back to them any time. Thousands of babies are heading into winter without full protection against RSV despite mounting evidence that free immunisations ...

urges a rollout of either the RSVpreF maternal immunisation or the monoclonal antibody treatment, nirsevimab, to shield infants from severe infection. RSV has long been overlooked, despite causing ...

An antibody treatment for respiratory syncytial virus (RSV) appears to be more effective at protecting infants from severe illness than vaccination during pregnancy. The new drugs preventing ...

She is urging people to get their babies vaccinated against the virus. The WA government has extended its free RSV immunisation program, which the preventative health minister says reduced ...

New Delhi: The World Health Organization (WHO) on Friday recommended all countries to use both maternal vaccine and a monoclonal antibody to protect babies against respiratory syncytial virus (RSV ...

Infants aged 0-3 months are at the highest risk for severe RSV disease.” In recent years, two preventive treatments were developed to reduce the severity of RSV infection: a maternal RSV vaccine to ...

It is also important to speak with a doctor so they can determine whether there are underlying causes, such as a virus or bacteria. Bacterial or antiviral medications alone will not work with RSV ...